MAPT and Alzheimer disease: One factor that surely played an important role was the fact that a large amount of AD research funding went to scientists studying Aβ and Tau, in order to test the hypothesis that confiscating or reducing Aβ and Tau protein aggregates in the brain could have a strong impact on cognitive function.